TP53-dependence on the effect of doxorubicin and Src inhibitor combination therapy
The anticancer effects of Src kinase inhibitors are controversial. This study found an association between alterations in the TP53 gene and the synergy score for combination treatment with doxorubicin and an Src kinase inhibitor using human osteosarcoma cell lines (MG63 and U2OS) and human colon can...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2018-08-01
|
| Series: | Tumor Biology |
| Online Access: | https://doi.org/10.1177/1010428318794217 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|